South Miami Hospital Harry Kapp Symposium, 27th Annual - New Trends in Pulmonary Medicine

Miami, FL US
October 23, 2019

COPD is a common chronic respiratory ailment and a major driver of health care expenditure. Creating care plans for patients with COPD requires concurrent attention to nuances in disease presentation and the application of multidisciplinary resources to optimize health care utilization. This symposium will address immunotherapy and novel bronchoscopic therapy for lung cancer, endobronchial lung volume reduction for severe COPD, sarcoidosis, nontuberculous mycobacterial (NTM) infection, and ECMO for respiratory failure. 

Target Audience

Pulmonologists, Critical Care Medicine Physicians, Pathologists, Family Practice Physicians, General Internists, Hospitalists, Nurses, Respiratory Therapists, Occupational Therapists, Pharmacists and other interested healthcare providers.

 

Learning Objectives

  • Discuss some of the latest research on acute respiratory distress syndrome (ARDS)
  • Implement evidence-based strategies in the treatment of patients with ARDS to improve patient outcomes. 
  • Asses the effectiveness of endoscopic lung volume reduction (ELVR) in patients with advanced emphysema. 
  • Effectively identify patients that will benefit from ELVR to manage severe COPD. 
  • Identify patient’s failure that would benefit from ECMO support.
  • Recognize the importance timing in referral, transportation and cannulation in the management of ECMO. 
  • Asses potential complications and outcomes of ECMO support for respiratory failure. 
  • Assess indications and contraindications for lung transplant. 
  • Distinguish factors that influence the rank of the patient on lung transplant waitlist. 
  • Review epidemiology of nontuberculous mycobacterial (NTM) and assess clinical presentation of pulmonary and extra-pulmonary NTM.
  • Effectively evaluate diagnostic approaches of NTM and treatment options to improve patient outcomes. 
  • Discuss the epidemiology of sarcoidosis.
  • Assess the clinical presentation of pulmonary and extra-pulmonary sarcoidosis.
  • Define diagnostic approach and treatment options.
Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Florida Board of Nursing
  • 6.00 Nurse Practitioners
  • 6.00 Florida Board of Occupational Therapy
  • 6.00 Florida Board of Respiratory Therapy
  • 6.00 General certificate of attendance
Course opens: 
05/19/2019
Course expires: 
11/29/2019
Event starts: 
10/23/2019 - 8:30am
Event ends: 
10/23/2019 - 3:30pm
Rating: 
0

AGENDA
7:30 a.m.      Registration
8:00 a.m.      Welcome and Introductions
8:15 a.m.      Immunotherapy and Novel Bronchoscopic Therapy for Lung Cancer - Rabih Bechara, M.D. 
9:15 a.m.      Who May Have Sarcoidosis And What Should You Do? - Mehdi Mirsaeidi, M.D. 
10:15 a.m.    Break
10:30 a.m.    Is Nontuberculous Mycobacterial (NTM) Infection a Serious Health Concern? - Mehdi Mirsaeidi, M.D. 
11:30 a.m.    Indications for Lung Transplantation:  When to Refer and When to List - Neejar Sinha, M.D. 
12:30 p.m.    Lunch
1:30 p.m.      Endobronchial Lung Volume Reduction for Severe COPD - Sajive Aleyas, M.D. 
2:30 p.m.      ECMO for Respiratory Failure, 2019 update - Hassan Alnuaimat, M.D. 
3:30 p.m.      Adjourn

South Miami Hospital
6200 SW 73 St
Victor E. Clarke Auditorium
Miami, FL 33143
United States

Rabih Bechara, M.D., FCCP
Professor of Medicine
Medical College of Georgia
Augusta, Georgia

Rabih Bechara, M.D. indicated that neither he nor his spouse/partner have relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation or discussion.

Sajive Aleyas, M.D. 
Director of Interventional Pulmonary Program, 
Director Respiratory Center Lung Cancer Program 
Cleveland Clinic Florida

Sajive Aleyas, M.D. has indicated that neither he nor his spouse/partner have relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation or discussion.

Hassan M. Alnuaimat, M.D. 
Associate Professor
Medical Director, Respiratory ECMO Program
University of Florida 
Gainesville, Florida 

Hassan M. Alnuaimat, M.D. has indicated that neither he nor his spouse/partner have relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation or discussion.

Neeraj Sinha, M.D.
Associate Professor 
Director of Transplant Pulmonology

Neeraj Sinha, M.D. indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

Mehdi Mirsaeidi, M.D., MPH
Director of UM and VA Sarcoidosis Programs
Co-Director UM NTM Program
IRB Vice-Chairman, Miami VA Healthcare System
Assistant Professor of Department of Medicine
Assistant Professor of Clinical Public Health Sciences
Division of Pulmonary, Critical Care,  
Sleep and Allergy
University of Miami Miller School of Medicine 
Miami, Florida

Mehdi Mirsaeidi, M.D. has indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
*Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 6 credit hours by the Florida Boards of Medicine, Osteopathic Medicine, and the Florida Council of Physician Assistants. CE Broker #20-738744.

This activity has also been approved for 6 credits for Nurses, Nurse Practitioners, Occupational Therapists and Respiratory Therapists (Direct delivery). Baptist Health South Florida CE Broker Provider #50-182.

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME.  Individuals are responsible for checking with the AANPCB for further guidelines.

.

 

Available Credit

  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Florida Board of Nursing
  • 6.00 Nurse Practitioners
  • 6.00 Florida Board of Occupational Therapy
  • 6.00 Florida Board of Respiratory Therapy
  • 6.00 General certificate of attendance

Accreditation Period

Course opens: 
05/19/2019
Course expires: 
11/29/2019
Please login or register to take this course.

Required Hardware/software

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.

Technical Support